Terms: = Lung cancer AND CASC5, AF15Q14, 57082, ENSG00000137812, D40, Q8NG31 AND Treatment
8 results:
1. Pricing methods in outcome-based contracting: δ1: cost effectiveness analysis and cost-utility analysis-based pricing.
Alkhatib NS; Ramos K; Erstad B; Slack M; McBride A; Bhattacharjee S; Abraham I
J Med Econ; 2020 Nov; 23(11):1215-1222. PubMed ID: 32845794
[TBL] [Abstract] [Full Text] [Related]
2. Pricing methods in outcome-based contracting: δ6: adherence-based pricing.
Alkhatib NS; Slack M; Bhattacharjee S; Erstad B; Ramos K; McBride A; Abraham I
J Med Econ; 2020 Nov; 23(11):1256-1265. PubMed ID: 32845209
[TBL] [Abstract] [Full Text] [Related]
3. Pricing methods in outcome-based contracting: δ4: safety-based pricing.
Alkhatib NS; Bhattacharjee S; McBride A; Ramos K; Slack M; Erstad B; Abraham I
J Med Econ; 2020 Nov; 23(11):1237-1245. PubMed ID: 32845205
[TBL] [Abstract] [Full Text] [Related]
4. Pricing methods in outcome-based contracting: δ5: risk of efficacy failure-based pricing.
Alkhatib NS; McBride A; Bhattacharjee S; Ramos K; Erstad B; Slack M; Billheimer D; Abraham I
J Med Econ; 2020 Nov; 23(11):1246-1255. PubMed ID: 32845204
[TBL] [Abstract] [Full Text] [Related]
5. Pricing methods in outcome-based contracting: δ2: willingness-to-pay-based pricing.
Alkhatib NS; Ramos K; Erstad B; Slack M; McBride A; Bhattacharjee S; Abraham I
J Med Econ; 2020 Nov; 23(11):1223-1229. PubMed ID: 32845201
[TBL] [Abstract] [Full Text] [Related]
6. Pricing methods in outcome-based contracting: δ3: reference-based pricing.
Alkhatib NS; Erstad B; Ramos K; McBride A; Bhattacharjee S; Slack M; Abraham I
J Med Econ; 2020 Nov; 23(11):1230-1236. PubMed ID: 32845191
[TBL] [Abstract] [Full Text] [Related]
7. Pricing methods in outcome-based contracting: integration analysis of the six dimensions (6 δs).
Alkhatib NS; McBride A; Slack M; Bhattacharjee S; Erstad B; Ramos K; Abraham I
J Med Econ; 2020 Nov; 23(11):1266-1272. PubMed ID: 32845180
[TBL] [Abstract] [Full Text] [Related]
8. A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy.
Chen YM; Shih JF; Perng RP; Tsai CM; Whang-Peng J
Chest; 2006 Apr; 129(4):1031-8. PubMed ID: 16608954
[TBL] [Abstract] [Full Text] [Related]
